Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations
Clinical trial NCT04511533 · COMPLETED
Trial details
- NCT number
- NCT04511533
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2022-10-15
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.